sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> meningococcal vaccines market

report

Meningococcal Vaccines Market, by Composition (Mono Vaccines, Combination Vaccine), Formulations (Conjugate Base Vaccines, Combination Base Vaccines, Polysaccharide Base Vaccines), Indications (Meningitis, Pneumonias, Bacteraemia) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC157 November 2016 100+ FREE 10% CUSTOMIZATION

The global meningococcal vaccines market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the meningococcal vaccines market.

KEY BENEFITS OF THE REPORT

  • Thorough understanding of the dynamics influencing the various segments of this market
  • Detailed analysis of the regulatory environment impacting the growth of this market
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The essential driver for the meningococcal vaccines market includes the increased production of cutting-edge serotype B immunizations from the leading drug makers such as Novartis and Pfizer.
  • The development of a regular vaccination programs across various parts of the world is genuinely necessary for the business achievement of these antibodies.
  • The increased financing and the government mandates about vaccination during childbirth will likewise diminish out-of-pocket costs of patients and increase moderate access to the meningitis antibodies.
  • Further, the higher frequency of the overall meningococcal infections among the newborn children and adults is also one of the major drivers for the meningococcal vaccines market.
  • However, management of the costs and tackling the competitor prices of the similar products is one of the major hindrances for the global market.
  • The other hindrance includes the expanding financial issues in the European countries, which are hampering the research and development activities in the meningococcal vaccines market.
  • Further, serotype confounds and not as much as ideal scope crosswise over nations is prone to contrarily influence the interest for the immunizations.
  • A deferral in surveying the ailment the study of disease transmission over standard interims because of the cost issues may adversely affect the meningococcal vaccines market over the long haul, especially in the creating countries.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s meningococcal vaccines market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the meningococcal vaccines market by the following segments:

  • Meningococcal Vaccines Market, by Compositions
    • Combination Vaccine
      • Bivalent vaccines
      • Tetravalent vaccine
      • Trivalent vaccines
    • Mono Vaccines
  • Meningococcal Vaccines Market, by Formulations
    • Combination Base Vaccines
    • Conjugate Base Vaccines
    • Polysaccharide Base Vaccines
  • Meningococcal Vaccines Market, by Indications
    • Bacteraemia
    • Meningitis
    • Pneumonia

KEY MARKET PLAYERS

Key players in the meningococcal vaccines market include:

  • Novartis AG, Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Baxter International, Inc.
  • Sanofi
  • JN-International Medical Corporation
  • Beijing Minhai Biotechnology
  • Serum Institute of India
  • Bio Med
  • Hualan Biological Engineering
  • Imunoloski Zavod
  • Nuron Biotech
  • Vacunas Finlay
  • GlycoVaxyn
  • Merck & Co.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Meningococcal Vaccines Market

TRENDING RELATED REPORT

Synthetic Biology Market, by Product (Core Products and Enabling Products), Application (Chemical, Healthcare and Agriculture), Technology (Genome Engineering, DNA Sequencing, Bioinformatics and Biological Components and Integration Systems) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
    4. Assumption
    5. Limitation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. MENINGOCOCCAL VACCINES MARKET, BY COMPOSITIONS
    1. Segment Share
    2. Compositions
      1. Combination Vaccine
        1. Bivalent vaccines
        2. Tetravalent vaccine
        3. Trivalent vaccines
      2. Mono Vaccines
  6. MENINGOCOCCAL VACCINES MARKET, BY FORMULATIONS
    1. Segment Share
    2. Formulations
      1. Combination Base Vaccines
      2. Conjugate Base Vaccines
      3. Polysaccharide Base Vaccines
  7. MENINGOCOCCAL VACCINES MARKET, BY INDICATIONS
    1. Segment Share
    2. Indications
      1. Bacteraemia
      2. Meningitis
      3. Pneumonia
  8. MENINGOCOCCAL VACCINES MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Compositions
      3. By Formulations
      4. By Indications
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K
        4. Rest of Europe
      2. By Compositions
      3. By Formulations
      4. By Indications
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Compositions
      3. By Formulations
      4. By Indications
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East and Africa
      2. By Compositions
      3. By Formulations
      4. By Indications
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players
  10. KEY MARKET PLAYERS
    1. Baxter International, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Beijing Minhai Biotechnology
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Bio Med, Hualan Biological Engineering
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. GlaxoSmithKline plc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Merck & Co.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Sanofi S.A.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Serum Institute of India
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Vacunas Finlay
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us